Antibiotic News and Research

RSS

Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.

Researchers identify chemical substance to treat bacterial infections

Increasing numbers of bacteria are developing antibiotic resistance. This forms a significant challenge in the battle against bacterial infections. Alvin Lo and Han Remaut (VIB/Vrije Universiteit Brussel) have identified a chemical substance with the potential of acting as a new drug to treat bacterial infections, particularly urinary tract infections.

29 Jan 2014

NPS MedicineWise urges health professionals to take the pledge to fight antibiotic resistance

NPS MedicineWise is urging all health professionals to take the pledge to fight antibiotic resistance after new research shows that making a public commitment leads to significant improvements in antibiotic prescribing.

29 Jan 2014

Scientists produce new version of old antibiotic that is active against difficult-to-treat tuberculosis

St. Jude Children's Research Hospital scientists have discovered a promising new class of antibiotics that could aid efforts to overcome drug-resistance in tuberculosis (TB), a global killer.

28 Jan 2014

Researchers discover unusually large bacteriophage that infects anthrax bacterium

From a zebra carcass on the plains of Namibia in Southern Africa, an international team of researchers has discovered a new, unusually large virus (or bacteriophage) that infects the bacterium that causes anthrax.

28 Jan 2014

FOB Synthesis enters into license agreement with AstraZeneca to treat drug-resistant bacterial infections

FOB Synthesis, Inc. has entered into a research and development option and license agreement with AstraZeneca for the development of a novel antibiotic to treat drug-resistant bacterial infections.

28 Jan 2014

New versions of old antibiotic offers strategy for overcoming drug resistance

Research led by St. Jude Children's Research Hospital scientists has produced new versions of an old antibiotic that are active against difficult-to-treat tuberculosis; offers new strategy for overcoming drug resistance

28 Jan 2014

Scientists start clinical trial of EDP-788 oral antibiotic to treat MRSA infections

Scientists have begun the first human clinical trial of EDP-788, an investigational oral antibiotic intended to treat methicillin-resistant Staphylococcus aureus (MRSA) infections.

27 Jan 2014

Study finds new class of semisynthetic anti-tuberculosis agents that overcome native drug efflux

Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have developed a method to synthesize modified forms of an established antibiotic called spectinomycin.

27 Jan 2014

NextSource BioTechnology announces product re-launch, market availability of Lomustine in U.S.

NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.

27 Jan 2014

ITAC assists in international distribution of NanoLogix products by Nasaem Al-Jazira

NanoLogix Inc. (NNLX), an innovator in the rapid detection, identification and determination of antibiotic resistance and sensitivity of live bacteria, announces that the State of Ohio Department of Economic Development's International Trade Assistance Center (ITAC) based at Youngstown State University (YSU) is providing support to Hubbard Ohio-based NanoLogix Inc. for international distribution of NanoLogix products by Nasaem Al-Jazira, a Saudi Arabian Trading and Distribution Company.

27 Jan 2014

E.R. expert warns public about 5 things doctor may do wrong when treating for flu

The flu season is in full swing starting mostly in the second week of January when emergency rooms are more busy than usual with patient with flu like symptoms. Dr. James Kojian, E.R. expert and founder of DRTOHELP.COM, warns the public about five things your doctor may be doing wrong when treating for the flu.

25 Jan 2014

New study identifies correlation between cranberry juice consumption and healthy body composition

As the New Year kicks off and resolutions become reality, cranberry juice lovers can feel good knowing their favorite cranberry products are the perfect solution to a healthy 2014. A recent study published in Nutrients, a peer-reviewed scientific journal published by MDPI, identified a correlation between cranberry juice consumption and healthy body composition. The study joins the list of mounting evidence highlighting the fruit's exceptional health benefits, giving consumers one more reason to feel good about enjoying the festive fruit every day, everywhere, every way.

23 Jan 2014

Scientists develop new genetic platform that yields novel antibiotic from ocean bacteria

Scientists at the University of California, San Diego have developed a new genetic platform that allows efficient production of naturally occurring molecules, and have used it to produce a novel antibiotic compound.

23 Jan 2014

Use of fever-reducing drugs may lead to tens of thousands more influenza cases

Contrary to popular belief, fever-reducing medication may inadvertently cause more harm than good. New research from McMaster University has discovered that the widespread use of medications that contain fever-reducing drugs may lead to tens of thousands more influenza cases, and more than a thousand deaths attributable to influenza, each year across North America.

22 Jan 2014

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

Forest Laboratories, Inc., a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, announced that reported diluted earnings per share equaled $0.07 in the third quarter of fiscal 2014, compared to a reported loss per share of ($0.58) in the third quarter of fiscal 2013. The third quarter of fiscal 2014 included a $45 million charge ($28.2 million net of tax) related to Project Rejuvenate.

21 Jan 2014

Researchers uncover how typhoid pathogen manages to evade host's immune system

The life-threatening disease typhoid fever results from the ongoing battle between the bacterial pathogen Salmonella and the immune cells of the body. Prof. Dirk Bumann's research group at the Biozentrum of the University of Basel has now uncovered how the typhoid pathogen repeatedly manages to evade the host's immune system. Their findings are published in the scientific journal "Cell Host & Microbe".

20 Jan 2014

Study shows high-fiber diet reduces risk of colon problems

Scientists have more reasons for you to eat fiber and not abuse antibiotics.

17 Jan 2014

RoundTable Healthcare Partners sells Aqua Pharmaceuticals Holdings for $402.6M to Almirall

RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has completed the sale of Aqua Pharmaceuticals Holdings, Inc. to Almirall S.A. for up to $402.6 million in cash

16 Jan 2014

TaiGen, R-Pharm sign exclusive agreement to develop and commercialize nemonoxacin

TaiGen Biotechnology Company, Limited today announced that they have signed an exclusive agreement with R-Pharm, a leading Russian pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn) in the Russian Federation, Turkey and other members of the Commonwealth Independent States.

15 Jan 2014

Scientists progress towards understanding how some bacterial cells escape being killed by antibiotics

Scientists have made an important advance in understanding how a subset of bacterial cells escape being killed by many antibiotics.

10 Jan 2014

Antibiotic News and Research

Further Reading

Researchers identify chemical substance to treat bacterial infections

NPS MedicineWise urges health professionals to take the pledge to fight antibiotic resistance

Scientists produce new version of old antibiotic that is active against difficult-to-treat tuberculosis

Researchers discover unusually large bacteriophage that infects anthrax bacterium

FOB Synthesis enters into license agreement with AstraZeneca to treat drug-resistant bacterial infections

New versions of old antibiotic offers strategy for overcoming drug resistance

Scientists start clinical trial of EDP-788 oral antibiotic to treat MRSA infections

Study finds new class of semisynthetic anti-tuberculosis agents that overcome native drug efflux

NextSource BioTechnology announces product re-launch, market availability of Lomustine in U.S.

ITAC assists in international distribution of NanoLogix products by Nasaem Al-Jazira

E.R. expert warns public about 5 things doctor may do wrong when treating for flu

New study identifies correlation between cranberry juice consumption and healthy body composition

Scientists develop new genetic platform that yields novel antibiotic from ocean bacteria

Use of fever-reducing drugs may lead to tens of thousands more influenza cases

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

Researchers uncover how typhoid pathogen manages to evade host's immune system

Study shows high-fiber diet reduces risk of colon problems

RoundTable Healthcare Partners sells Aqua Pharmaceuticals Holdings for $402.6M to Almirall

TaiGen, R-Pharm sign exclusive agreement to develop and commercialize nemonoxacin

Scientists progress towards understanding how some bacterial cells escape being killed by antibiotics

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News